Hyperion Therapeutics
2000 Sierra Point Parkway
Suite 400
San Francisco
California
94005
United States
Tel: 1-650-745-7802 or 1-888-897-4276
Fax: 650-871-7029
Website: http://www.hyperiontx.com/
109 articles about Hyperion Therapeutics
-
Clal Biotech Opts Out of Re-Acquiring Andromeda from Hyperion After Phase III Diabetes Drug Tanks
10/7/2015
-
Horizon Pharma Completes Acquisition Of Hyperion Therapeutics
5/7/2015
-
Horizon Pharma Announces Expiration Of HSR Waiting Period For Proposed Hyperion Therapeutics Acquisition
4/30/2015
-
Horizon Pharma Acquires Hyperion Therapeutics and Its Revenue-Boosting Pipeline for $1.1B
3/31/2015
-
Horizon Pharma To Acquire Hyperion Therapeutics For $46.00 Per Share Or $1.1 Billion In Cash
3/30/2015
-
Hyperion Therapeutics To Present At 27th Annual ROTH Conference
3/6/2015
-
Hyperion Therapeutics Observes Rare Disease Day 2015
2/27/2015
-
Hyperion Therapeutics Announces Fourth Quarter And Full Year 2014 Financial Results
2/27/2015
-
Hyperion Therapeutics To Present At The Cowen and Company 35th Annual Health Care Conference
2/26/2015
-
Hyperion Therapeutics To Report Fourth Quarter And Full Year 2014 Financial Results After Market On February 26, 2015
2/20/2015
-
Hyperion Therapeutics Enters Into Completion Of Phase III Clinical Trial, Option And Mutual Release Agreement With Clal Biotechnology Industries And Yeda Research and Development Company Ltd.
2/17/2015
-
Hyperion Therapeutics Initiates Clinical Study To Further Evaluate Ravicti In Pediatric Subjects Under Two Years Of Age With Urea Cycle Disorders
2/10/2015
-
Hyperion Therapeutics To Present At The 2015 Leerink Global Healthcare Conference
2/5/2015
-
Hyperion Therapeutics Announces Data Published In Genetics In Medicine Showing Blood Ammonia And Glutamine As Predictors Of Hyperammonemic Crises In Patients With Urea Cycle Disorders
1/12/2015
-
Hyperion Therapeutics Added To Nasdaq Biotechnology Index (NBI)
12/19/2014
-
Hyperion Therapeutics To Present At The Oppenheimer 25th Annual Healthcare Conference
12/5/2014
-
Hyperion Therapeutics To Present At The Jefferies and Co. 2014 Global London Healthcare Conference
11/14/2014
-
Hyperion Therapeutics To Report Third Quarter 2014 Financial Results After Market On November 6, 2014
10/31/2014
-
Hyperion Therapeutics, Clal Biotechnology Industries Resolve Dispute Over $570 Million Biotech Problem
10/7/2014
-
Hyperion Therapeutics To Present At The Leerink Rare Disease Roundtable
9/25/2014